A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)

PHASE3TerminatedINTERVENTIONAL
Enrollment

468

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

PD 0332334

Dosage Form: 25 or 100 mg oral capsules Dosage and frequency: 350-600 mg twice a day Duration: 1 year

Trial Locations (93)

10023

Pfizer Investigational Site, New York

10024

Pfizer Investigational Site, New York

10467

Pfizer Investigational Site, The Bronx

11235

Pfizer Investigational Site, Brooklyn

14618

Pfizer Investigational Site, Rochester

18104

Pfizer Investigational Site, Allentown

19063

Pfizer Investigational Site, Media

19139

Pfizer Investigational Site, Philadelphia

19401

Pfizer Investigational Site, Norristown

21208

Pfizer Investigational Site, Baltimore

22903

Pfizer Investigational Site, Charlottesville

27607

Pfizer Investigational Site, Raleigh

29201

Pfizer Investigational Site, Columbia

30060

Pfizer Investigational Site, Marietta

30308

Pfizer Investigational Site, Atlanta

30328

Pfizer Investigational Site, Atlanta

32216

Pfizer Investigational Site, Jacksonville

32701

Pfizer Investigational Site, Altamonte Springs

32751

Pfizer Investigational Site, Maitland

32763

Pfizer Investigational Site, Orange City

32806

Pfizer Investigational Site, Orlando

33126

Pfizer Investigational Site, Miami

33143

Pfizer Investigational Site, Miami

Pfizer Investigational Site, South Miami

33407

Pfizer Investigational Site, West Palm Beach

33912

Pfizer Investigational Site, Fort Myers

35226

Pfizer Investigational Site, Birmingham

38119

Pfizer Investigational Site, Memphis

38134

Pfizer Investigational Site, Memphis

42301

Pfizer Investigational Site, Owensboro

43210

Pfizer Investigational Site, Columbus

43609

Pfizer Investigational Site, Toledo

43623

Pfizer Investigational Site, Toledo

45408

Pfizer Investigational Site, Dayton

46143

Pfizer Investigational Site, Greenwood

47802

Pfizer Investigational Site, Terre Haute

53562

Pfizer Investigational Site, Middleton

60048

Pfizer Investigational Site, Libertyville

60068

Pfizer Investigational Site, Park Ridge

60563

Pfizer Investigational Site, Naperville

66206

Pfizer Investigational Site, Prairie Village

66212

Pfizer Investigational Site, Overland Park

67207

Pfizer Investigational Site, Wichita

68131

Pfizer Investigational Site, Omaha

70601

Pfizer Investigational Site, Lake Charles

73008

Pfizer Investigational Site, Bethany

73103

Pfizer Investigational Site, Oklahoma City

73116

Pfizer Investigational Site, Oklahoma City

75115

Pfizer Investigational Site, DeSoto

75230

Pfizer Investigational Site, Dallas

75231

Pfizer Investigational Site, Dallas

77008

Pfizer Investigational Site, Houston

77074

Pfizer Investigational Site, Houston

77566

Pfizer Investigational Site, Lake Jackson

78229

Pfizer Investigational Site, San Antonio

78756

Pfizer Investigational Site, Austin

80239

Pfizer Investigational Site, Denver

85340

Pfizer Investigational Site, Litchfield Park

87109

Pfizer Investigational Site, Albuquerque

89146

Pfizer Investigational Site, Las Vegas

90210

Pfizer Investigational Site, Beverly Hills

91106

Pfizer Investigational Site, Pasadena

91316

Pfizer Investigational Site, Encino

91403

Pfizer Investigational Site, Sherman Oaks

91786

Pfizer Investigational Site, Upland

91950

Pfizer Investigational Site, National City

92025

Pfizer Investigational Site, Escondido

92103

Pfizer Investigational Site, San Diego

92108

Pfizer Investigational Site, San Diego

92374

Pfizer Investigational Site, Redlands

92562

Pfizer Investigational Site, Murrieta

92591

Pfizer Investigational Site, Temecula

92595

Pfizer Investigational Site, Wildomar

92626

Pfizer Investigational Site, Costa Mesa

92627

Pfizer Investigational Site, Costa Mesa

92868

Pfizer Investigational Site, Orange

97210

Pfizer Investigational Site, Portland

97301

Pfizer Investigational Site, Salem

98104

Pfizer Investigational Site, Seattle

91007-3462

Pfizer Investigational Site, Arcadia

92660-2452

Pfizer Investigational Site, Newport Beach

06518

Pfizer Investigational Site, Hamden

06360

Pfizer Investigational Site, Norwich

02478

Pfizer Investigational Site, Belmont

02135

Pfizer Investigational Site, Boston

02721

Pfizer Investigational Site, Fall River

01830

Pfizer Investigational Site, Haverhill

01201

Pfizer Investigational Site, Pittsfield

03060

Pfizer Investigational Site, Nashua

10128-1708

Pfizer Investigational Site, New York

02865

Pfizer Investigational Site, Lincoln

05091

Pfizer Investigational Site, Woodstock

53188-1660

Pfizer Investigational Site, Waukesha

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00735267 - A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD) | Biotech Hunter | Biotech Hunter